Characterization of serum interleukin-15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker

European Cytokine Network

Volumn 21, Issue 3, 2010, Pages 186-194

  Lamana, Amalia ^a   Ortiz, Ana M ^a   Alvaro Gracia, José M ^a   Díaz Sánchez, Belén ^a   Novalbos, Jesús ^a   García Vicuña, Rosario ^a   González Álvaro, Isidoro ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Circadian rhythm; Early arthritis; Interleukin 15; Rheumatoid arthritis

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 15; MESSENGER RNA; PRIMER DNA;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTHRITIS; ARTICLE; BLOOD LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; BLOOD; ENZYME IMMUNOASSAY; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; BASE SEQUENCE; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; DNA PRIMERS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-15; MALE; MIDDLE AGED; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77957339518     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2010.0203     Document Type: Article

References (25)

1. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996; 4: 329.
2. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001; 97: 14.
3. McInnes IB, al-Mughales J, Field M, et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996; 2: 175 [see comments].
4. Thurkow EW, van der Heijden IM, Breedveld FC, et al. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J Pathol 1997; 181: 444.
5. Ortiz AM, Laffon A, Gonzalez-Alvaro I. CD69 expression on lymphocytes and interleukin-15 levels in synovial fluids from different inflammatory arthropathies. Rheumatol Int 2002; 21: 182.
6. Ziolkowska M, Koc A, Luszczykiewicz G, et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000; 164: 2832.
7. Cordero OJ, Salgado FJ, Mera-Varela A, Nogueira M. Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis. Rheumatol Int 2001; 21: 69.
8. Suzuki J, Morimoto S, Amano H, Tokano Y, Takasaki Y, Hashimoto H. Serum levels of interleukin 15 in patients with rheumatic diseases. J Rheumatol 2001; 28: 2389.
9. Gonzalez-Alvaro I, Ortiz AM, Garcia-Vicuna R, Balsa A, Pascual-Salcedo D, Laffon A. Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease. Clin Exp Rheumatol 2003; 21: 639.
10. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 1997; 3: 189.
11. Miranda-Carus ME, Balsa A, Benito-Miguel M, Perez de Ayala C, Martin-Mola E. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J Immunol 2004; 173: 1463.
12. Gonzalez-Alvaro I, Dominguez-Jimenez C, Ortiz AM, et al. Interleukin-15 and interferon-gamma participate in the cross-talk between natural killer and monocytic cells required for tumour necrosis factor production. Arthritis Res Ther 2006; 8: R88.
13. Gonzalez-Alvaro I, Ortiz AM, Romero FI, Laffon A, Sanchez-Madrid F. CD69 expression on lymphocytes is a key event in the TNF-alpha production mediated by intercellular contacts between macrophages and IL-15-activated lymphocytes. Rheumatology (Oxford) 2002; 41: S26.
14. Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen- induced immunopathology. J Immunol 1998; 160: 5654.
15. Baslund B, Tvede N, Danneskiold-Samsoe B, et al. Targeting interleukin-15 in patients with rheumatoid arthritis: A proof-of-concept study. Arthritis Rheum 2005; 52: 2686.
16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315.
17. Esteve-Vives J, Batlle-Gualda E, Reig A. Spanish version of the Health Assessment Questionnaire: reliability, validity and transcultural equivalency. Grupo para la Adaptacion del HAQ a la Poblacion Espanola. J Rheumatol 1993; 20: 2116.
18. Cutolo M, Straub RH. Circadian rhythms in arthritis: Hormonal effects on the immune/inflammatory reaction. Autoimmun Rev 2008; 7: 223.
19. Onu A, Pohl T, Krause H, Bulfone-Paus S. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol 1997; 158: 255.
20. Tagaya Y, Kurys G, Thies TA, et al. Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci USA 1997; 94: 14444.
21. Meazza R, Gaggero A, Neglia F, et al. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur J Immunol 1997; 27: 1049.
22. Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849.
23. Miranda-Carus ME, Benito-Miguel M, Balsa A, et al. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum 2006; 54: 1151.
24. Gonzalez-Alvaro I, Ortiz A, Tomero E, et al. El bloqueo terapéutico del factor de necrosis tumoral disminuye la concentración sérica de interleucina 15 en pacientes con artritis reumatoide. Rheumatol Clin 2009; 5: 23.
25. Rueda B, Lopez-Nevot MA, Gonzalez-Gay MA, et al. Molecular screening and association study of IL15 gene polymorphisms in rheumatoid arthritis. Cytokine 2007; 38: 84.